It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

The company, carrying a Zacks Rank #1 at present, has witnessed a 4.8% upward revision in broker ratings over the past four weeks. Get the remaining stock on the list and start putting this and ...

Zacks Dividend Fund earns an Average Process ... This strategy prefers more value-oriented stocks compared with the average fund in its peer group, the Large Value Morningstar Category.

Zacks Small-Cap Core Fund earns an Average Process ... with Morningstar Category peers in the last few years. Less-liquid stocks might offer strong returns to compensate for their risks, but ...

Additionally, these stocks have a favorable combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy ... increased traction as a growing number of organizations are adopting ...

Adaptimmune Therapeutics plc (NASDAQ:ADAP – Free Report) – Analysts at Zacks ... $3.00 to $1.75 and set a “buy” rating on the stock in a report on Wednesday. One analyst has rated the ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. Featuring daily updates ...

Additionally, these stocks have a favorable combination of a Growth Score of A or B and a Zacks Rank #1 (Strong Buy) or 2 (Buy). The Growth Style Score condenses all the essential metrics from a ...